Jagged1/2 inhibition promotes tumor cells response to Bortezomib in a zebrafish model of multiple myeloma
Matteo Colombo(Ospedale Civile Di Ivrea), Alfonso Neri, S. Garavelli(University of Milan), Anna Pistocchi(University of Milan), Mara Mazzola(University of Milan), G. Domenica, Maria Teresa Palano(University of Milan), Raffaella Chiaramonte(University of Milan), Natalia Platonova(University of Milan)
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano)
June 20, 2018
Cited by 0
Related Papers
Inflammatory bowel disease in children and adolescents in Italy: Data from the pediatric national IBD register (1996–2003)
|Inflammatory Bowel Diseases|2008|124
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells
|Biochemical Pharmacology|2007|118
Senescence-Dependent Regulation of Type 1 Plasminogen Activator Inhibitor in Human Vascular Endothelial Cells
|Experimental Cell Research|1995|110